|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 491/22 | (2006.01) |
| A61K 31/4745 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 47/68 | (2017.01) |
| (11) | Number of the document | 3316885 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16818645.0 |
| Date of filing the European patent application | 2016-06-29 | |
| (97) | Date of publication of the European application | 2018-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/040002 |
| Date | 2016-06-29 |
| (87) | Number | WO 2017/004144 |
| Date | 2017-01-05 |
| (30) | Number | Date | Country code |
| 201514789375 | 2015-07-01 | US | |
| 201615161806 | 2016-05-23 | US |
| (72) |
GOVINDAN, Serengulam V. , US
GALE, Jonathan B. , US
HOLMAN, Nicholas J. , US
GOLDENBERG, David M. , US
|
| (73) |
Immunomedics, Inc. ,
300 American Road, Morris Plains, NJ 07950,
US
|
| (54) | ANTIBODY-SN-38 IMMUNOCONJUGATES WITH A CL2A LINKER |
| ANTIBODY-SN-38 IMMUNOCONJUGATES WITH A CL2A LINKER |